Incorrect username and/or password, please try again or click to reset.

Class 4 Medicines Defect Information: Pfizer Limited, Depo-Medrone with Lidocaine 40 mg/mL (1 mL and 2 mL vials – single vial preparations), EL (22)A/18

2022-04-21 11:06:50 (2 month(s) ago)

Summary

Pfizer Limited have informed the MHRA that an outdated version of the Patient Information Leaflet (PIL) has been included in the packaging of the specific batches mentioned in this notification.

Read full MHRA article

Respond to this alert